Key result
Sudden cardiac death among competitive athletes has an incidence of 1-2 per 100,000 per annum and is most commonly caused by structural abnormalities like hypertrophic cardiomyopathy.
This review summarizes the etiologies, identification, and management of sudden cardiac death in competitive adult athletes based on current consensus guidelines.
Answers are grounded in this paper and cite their sources.
May guide athlete screening protocols; leaves open optimal prevention and risk stratification.
Sudden cardiac death is the leading cause of mortality among young athletes with an incidence of 1-2 per 100,000 athletes per annum. It is described as 'an event that is non-traumatic, non-violent, unexpected, and resulting from sudden cardiac arrest within six hours of previously witnessed normal health'. Most predisposed athletes have no symptoms and there is no warning for the impending tragic event. The majority of cases are caused by an underlying structural cardiac abnormality, most commonly hypertrophic cardiomyopathy. More recently, the understanding of non-structural causes such as long QT syndrome and Brugada syndrome has grown and diagnostic criteria have been developed. This review presents the known aetiologies of sudden cardiac death among athletes and outlines their identification and management including implications for future sporting participation as laid out in the consensus documents produced by the European Society of Cardiology and the 36th Bethesda Conference.
No takes yet. Share an insight, caveat, or question.
Pugh et al. (2012) conducted a review in Sudden cardiac death. Sudden cardiac death among competitive athletes has an incidence of 1-2 per 100,000 per annum and is most commonly caused by structural abnormalities like hypertrophic cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: